220 related articles for article (PubMed ID: 31833573)
1. The effectiveness and safety of topical β-receptor blocker in treating superficial infantile haemangiomas: A meta-analysis including 20 studies.
Lin Z; Zhang B; Yu Z; Li H
Br J Clin Pharmacol; 2020 Feb; 86(2):199-209. PubMed ID: 31833573
[TBL] [Abstract][Full Text] [Related]
2. Interventions for infantile haemangiomas of the skin.
Novoa M; Baselga E; Beltran S; Giraldo L; Shahbaz A; Pardo-Hernandez H; Arevalo-Rodriguez I
Cochrane Database Syst Rev; 2018 Apr; 4(4):CD006545. PubMed ID: 29667726
[TBL] [Abstract][Full Text] [Related]
3. The Efficacy and Safety of Topical β-Blockers in Treating Infantile Hemangiomas: A Meta-Analysis Including 11 Randomized Controlled Trials.
Wang X; Feng W; Zhao X; Liu Z; Dong L
Dermatology; 2021; 237(3):433-443. PubMed ID: 33027794
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the efficacy and safety of lasers, topical timolol, and combination therapy for the treatment of infantile hemangioma: A meta-analysis of 10 studies.
Huang H; Chen X; Cai B; Yu J; Wang B
Dermatol Ther; 2022 Dec; 35(12):e15907. PubMed ID: 36205218
[TBL] [Abstract][Full Text] [Related]
5. Local administration of β-blockers for infantile hemangiomas: a systematic review and meta-analysis.
Ovadia SA; Landy DC; Cohen ER; Yang EY; Thaller SR
Ann Plast Surg; 2015 Feb; 74(2):256-62. PubMed ID: 25590249
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of Combined Topical Timolol and Oral Propranolol for Treating Infantile Hemangioma: A Meta-Analysis of Randomized Controlled Trials.
Qiao J; Lin J; Zhang D; Li J; Chen C; Yu H; Li X; Fang B
Front Pharmacol; 2020; 11():554847. PubMed ID: 33132908
[TBL] [Abstract][Full Text] [Related]
7. Effect of topical timolol on response rate and adverse events in infantile hemangioma: a meta-analysis.
Zheng L; Li Y
Arch Dermatol Res; 2018 May; 310(4):261-269. PubMed ID: 29362868
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of adrenergic beta-antagonist combined with lasers in the treatment of infantile hemangiomas: a meta-analysis.
Chen X; Guo Y; Wang P; Qiu F; Sun Y; Shi Q; Deng Y; Hu C; Lei S
Pediatr Surg Int; 2020 Oct; 36(10):1135-1147. PubMed ID: 32647928
[TBL] [Abstract][Full Text] [Related]
9. Current concepts in the management of periocular infantile (capillary) hemangioma.
Ni N; Guo S; Langer P
Curr Opin Ophthalmol; 2011 Sep; 22(5):419-25. PubMed ID: 21730838
[TBL] [Abstract][Full Text] [Related]
10. Combined Oral and Topical Beta Blockers for the Treatment of Early Proliferative Superficial Periocular Infantile Capillary Hemangioma.
Marey HM; Elmazar HF; Mandour SS; Khairy HA
J Pediatr Ophthalmol Strabismus; 2018 Jan; 55(1):37-42. PubMed ID: 28991344
[TBL] [Abstract][Full Text] [Related]
11. The efficacy and safety of treatments for infantile hemangiomas: a Bayesian network meta-analysis.
Yang H; Hu DL; Xuan XX; Chen JJ; Xu S; Wu XJ; Zhang H; Shu Q; Guo XD
Int J Dermatol; 2020 Nov; 59(11):1320-1331. PubMed ID: 32662887
[TBL] [Abstract][Full Text] [Related]
12. An infant with localized vasoconstriction following topical propranolol exposure for infantile hemangioma.
Saerens J; Gutermuth J; Janmohamed SR
Pediatr Dermatol; 2021 Jan; 38(1):263-264. PubMed ID: 33275306
[TBL] [Abstract][Full Text] [Related]
13. Topical Timolol Maleate Treatment of Infantile Hemangiomas.
Püttgen K; Lucky A; Adams D; Pope E; McCuaig C; Powell J; Feigenbaum D; Savva Y; Baselga E; Holland K; Drolet B; Siegel D; Morel KD; Garzon MC; Mathes E; Lauren C; Nopper A; Horii K; Newell B; Song W; Frieden I;
Pediatrics; 2016 Sep; 138(3):. PubMed ID: 27527799
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the efficacy and safety of propranolol, timolol maleate, and the combination of the two, in the treatment of superficial infantile haemangiomas.
Gong H; Xu DP; Li YX; Cheng C; Li G; Wang XK
Br J Oral Maxillofac Surg; 2015 Nov; 53(9):836-40. PubMed ID: 26427968
[TBL] [Abstract][Full Text] [Related]
15. Review of topical beta blockers as treatment for infantile hemangiomas.
Painter SL; Hildebrand GD
Surv Ophthalmol; 2016; 61(1):51-8. PubMed ID: 26408055
[TBL] [Abstract][Full Text] [Related]
16. Topical Timolol for Infantile Haemangioma of the Orbit.
Hildebrand GD; Sipkova Z
Klin Monbl Augenheilkd; 2021 Oct; 238(10):1069-1076. PubMed ID: 34662921
[TBL] [Abstract][Full Text] [Related]
17. The effectiveness of propranolol in treating infantile haemangiomas: a meta-analysis including 35 studies.
Lou Y; Peng WJ; Cao Y; Cao DS; Xie J; Li HH
Br J Clin Pharmacol; 2014 Jul; 78(1):44-57. PubMed ID: 24033819
[TBL] [Abstract][Full Text] [Related]
18. Imiquimod 5% cream versus timolol 0.5% ophthalmic solution for treating superficial proliferating infantile haemangiomas: a retrospective study.
Qiu Y; Ma G; Yang J; Hu X; Chen H; Jin Y; Lin X
Clin Exp Dermatol; 2013 Dec; 38(8):845-50. PubMed ID: 23627540
[TBL] [Abstract][Full Text] [Related]
19. Topical timolol as adjunct therapy to shorten oral propranolol therapy for infantile hemangiomas.
Mannschreck DB; Huang AH; Lie E; Psoter K; Puttgen K
Pediatr Dermatol; 2019 May; 36(3):283-289. PubMed ID: 30968438
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and Safety of Oral Propranolol or Topical Timolol for the Treatment of Superficial Infantile Hemangiomas.
Han K; Wei J; Zheng H; Li X; Zhang A; Ma Y; Meng J; Hu Y
J Craniofac Surg; 2024 Feb; ():. PubMed ID: 38345941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
